Published in Pharma Investments, Ventures and Law Weekly, December 18th, 2005
Cortek, acquired by Alphatec Spine in September 2005, makes allografts for spinal interbody fusion.
Ronald G. Hiscock, CEO, said, "We see significant surgeon demand for the Cortek allograft products, especially when paired with the Alphatec line. To support Cortek's growth, Alphatec looked for an executive like Todd who had generated demand, increased sales, and managed dramatic internal growth. Alphatec is fortunate to have such an outstanding and experienced executive like Todd to grow the Cortek business and continue its integration into Alphatec...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly